 Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial:...  Meta-Analysis in Medicine and Health Policy - Page 103edited by - 2000 - 414 pagesLimited preview - About this book
 | Pia Glas-Greenwalt - Medical - 1995 - 286 pages
...heparin in patients with myocardial infarction and healthy volunteers. Circulation, 86. 1370, 1992. 72. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO). An international randomized trial comparing four thrombolytic strategies for acute myocardial... | |
 | 157 pages
...streptokinase to approximately $1,700 for APSAC and $2,200 for tPA. A subsequently reported trial, GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), which included comparisons of streptokinase and tPA, suggested that a newer method of administering... | |
 | DIANE Publishing Company - 1996 - 317 pages
...complex; GISSI = The Gruppo Italiano per lo Studio della Streptochinasi Nell' Infarto Miocardio; GUSTO = Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries; ISIS = International Study of Infarcì Survival; TPA = tissue-type plasminogen activator. SOURCE: Office... | |
 | R. C. Becker - Medical - 1998 - 660 pages
...observed higher rate of cerebral hemorrhage with t-PA compared with streptokinase [58]. The results of the Global Utilization of Streptokinase and Tissue...Plasminogen Activator for Occluded Coronary Arteries (GUSTO) 1 trial undoubtedly support the overall superiority of t-PA (alteplase) over streptokinase... | |
 | V. FUSTER - Science - 2000 - 918 pages
...(3). Se produjo shock cardiogénico en 2.972 (7,2%) de 41.021 pacientes participantes en el ensayo Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO- 1) (7a). La inmensa mayoría de los pacientes (89%) presentaron el shock después del ingreso,... | |
 | Michael R. Sanders, John B. Kostis - Medical - 2007 - 234 pages
...incidence of congestive heart failure, need for temporary pacemaker, stroke or recurrent infarction.3 In the Global Utilization of Streptokinase and Tissue...Plasminogen Activator for Occluded Coronary Arteries (GUSTO) trial, despite the higher stroke rates in women, there was no mortality difference between... | |
 | Richard F. Gillum, Philip B. Gorelick, Edward S. Cooper - Medical - 1999 - 242 pages
...Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue...Plasminogen Activator for Occluded Coronary Arteries (GUSTO) I Investigators. Circulation 1997;95:2508-2516. 9 The NINDS t-PA Stroke Study Group: Intracerebral... | |
 | M.Elizabeth Halloran, Donald Berry - Medical - 1999 - 300 pages
...plasminogen activator and streptokinase in acute myocardial infarction. The trial under review is called “Global Utilization of Streptokinase and Tissue...Plasminogen Activator for Occluded Coronary Arteries” or ‘GUSTO' for short. (The survival benefit over previous standard thrombolytic regimens. Joseph... | |
 | Pamela Charney - Medical - 1999 - 631 pages
...Study of Infarct Survival) (62), ASSET (Anglo-Scandinavian Study of Early Thrombolysis) (82), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) (65), and GISSI-1 (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) (66)... | |
 | Eric J. Topol - Medical - 2000 - 916 pages
...the mortality reduction in those treated between 3 and 6 hours was 17% in the laner study (Fig. 1). In the Global Utilization of Streptokinase and Tissue...Plasminogen Activator for Occluded Coronary Arteries (GUSTO 1) study (13), 30-day mortality rate in patients treated within 2 hours of onset of symptoms... | |
| |
